Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Complera
Complera was launched in the United States in 2011. [1]
Complera is a fixed-dose combination (FDC) of older antiretroviral components (rilpivirine with emtricitabine and tenofovir disoproxil fumarate), but it was introduced as a single once-daily tablet in 2011. [1]
DrugPatentWatch.com lists Complera’s launch year as 2011. [1]
Other Questions About Complera :